MEDPLUS

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, which will be available on the company's website and on the websites of BSE and NSE.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange about Credit Rating from CareEdge Ratings Limited for its subsidiary Optival Health Solutions Private Limited's long-term and short-term bank facilities.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange' due to non-compliance with SEBI LODR Regulations, 2015 regarding the appointment of a Non-Executive-Independent Director who has attained the age of seventy five years.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange regarding Outcome of Board Meeting held on September 10, 2026, where the Board of Directors has considered and approved the acquisition of the residual stake i.e. 0.01% of the total shareholding of Optival Health Solutions Private Limited, a material subsidiary of the Company.

Medplus Health Services Limited

Medplus Health Services Limited has submitted the Exchange a copy of the Scrutinizer's report of the Annual General Meeting held on August 17, 2026, and informed the Exchange regarding voting results.

Medplus Health Services Limited

Medplus Health Services Limited held its 20th Annual General Meeting on August 17, 2026, through video conferencing, with all necessary quorum present. The meeting was conducted in compliance with regulatory provisions and the company's auditors expressed an unqualified opinion on the financial statements for the year 2025-2026.

Medplus Health Services Limited

MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited due to potential revenue loss of Rs 0.24, Rs 0.17, and Rs 0.23 lakhs.

Medplus Health Services Limited

MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in Karnataka due to a contravention under the Drugs and Cosmetics Act, resulting in a potential revenue loss of Rs 0.71 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in the state of Telangana, resulting in a potential revenue loss of Rs 2.34 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license for a store in Karnataka due to a violation of the Drugs and Cosmetics Act, 1940.

Medplus Health Services Limited

MedPlus Health Services Limited has announced its Q1 FY27 earnings, with a consolidated revenue of INR18,796 million and a consolidated operating EBITDA of INR651 million, representing a 3.5% margin. The company has opened 222 stores and closed 52 stores, including 9 relocation cases and 27 franchisee outlet closures, with a net addition of 146 stores in the current quarter.

Medplus Health Services Limited

Medplus Health Services Limited has published a newspaper notice for the completion of dispatch of notice of its 20th Annual General Meeting, as per Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Medplus Health Services Limited

Medplus Health Services Limited has received three suspension orders for a Drug License of its subsidiary Optival Health Solutions Private Limited, resulting in potential revenue loss of Rs 2.4 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has released its Business Responsibility and Sustainability Report for the Financial Year 2025-26, as per SEBI regulations.

Medplus Health Services Limited

MedPlus Health Services Limited has announced its 20th Annual General Meeting (AGM) for the Financial Year 2025-26, scheduled to be held on August 17, 2026, through video conferencing. The meeting will consider the audited standalone and consolidated financial statements for the year ended March 31, 2026, and the appointment of two independent directors.

Medplus Health Services Limited

Medplus Health Services Limited has announced that its Board of Directors has kept in abeyance the CAPEX plans approved earlier, including the setting up of a Food Park by Optival Health Solutions Private Limited and a Concierge Health & Wellness Services Facility at Hyderabad. The company will continue to evaluate future growth opportunities and the abeyance of the CAPEX Plan is not expected to have any adverse impact on its existing operations or business performance.

Medplus Health Services Limited

MedPlus Health Services Limited has requested the stock exchanges to ignore an inadvertent filing of an investor presentation due to an unintended attachment. The company has since filed the correct presentation, and stakeholders are advised to refer to the subsequent filing.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange about the link of recording of the earnings call held on July 22, 2026, to discuss the financial results for the quarter ended June 30, 2026. The audio recording is available on the company's website and on the websites of BSE Limited and National Stock Exchange of India Ltd.

Medplus Health Services Limited

MedPlus Health Services Limited has announced the 20th Annual General Meeting (AGM) to be held on August 17, 2026 through video conferencing or other audio-visual means.